Quality Chemical Industries Limited (UGSE:QCIL)

Revenue by Segment

Financials in millions UGX. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	290.49B	267.13B	265.34B	221.47B	267.43B
Pharmaceuticals Growth	8.75%	0.67%	19.81%	-17.19%	-6.01%
Total	290.49B	267.13B	265.34B	221.47B	267.43B
Total Growth	8.75%	0.67%	19.81%	-17.19%	-6.01%

Revenue by Geography

Financials in millions UGX. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Uganda	242.29B	202.69B	169.82B	171.87B	187.49B
Uganda Growth	19.54%	19.36%	-1.20%	-8.33%	18.78%
Exports	48.20B	64.44B	95.52B	49.59B	79.94B
Exports Growth	-25.20%	-32.54%	92.62%	-37.96%	-36.90%
Total	290.49B	267.13B	265.34B	221.47B	267.43B
Total Growth	8.75%	0.67%	19.81%	-17.19%	-6.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 14, 2026

Data Sources Report a data error